About
Interested in big data, highly scalable systems and building them.
Activity
-
Entering the Major Cold, the last of the 24 solar terms, we finally felt the chill of winter. Amidst the swirling snowflakes, people happily played…
Entering the Major Cold, the last of the 24 solar terms, we finally felt the chill of winter. Amidst the swirling snowflakes, people happily played…
Liked by Xiaoting Ye
-
Jeff, a patient in our STARLIGHT Clinical Trial of MCO-010 for Stargardt Macular Degeneration shares his thoughts after receiving MCO-010 treatment…
Jeff, a patient in our STARLIGHT Clinical Trial of MCO-010 for Stargardt Macular Degeneration shares his thoughts after receiving MCO-010 treatment…
Liked by Xiaoting Ye
-
We welcome Naj Sharif, PhD, DSC to the Nanoscope Therapeutics Inc. team! Dr. Sharif joins our team as VP of Global Research and Development. “We are…
We welcome Naj Sharif, PhD, DSC to the Nanoscope Therapeutics Inc. team! Dr. Sharif joins our team as VP of Global Research and Development. “We are…
Liked by Xiaoting Ye
Experience
-
-
-
-
-
-
-
Education
Licenses & Certifications
Honors & Awards
-
Outstanding Graduate Scholarship
UESTC
top 5%
-
Outstanding Renmin Scholarship
UESTC
top 3%
-
First-class Renmin Scholarship
UESTC
Languages
-
Chinese
Native or bilingual proficiency
-
English
Full professional proficiency
More activity by Xiaoting
-
Unlike most other synapses in the brain, each individual cone synapse is connected to more than a dozen different types of post-synaptic neurons. In…
Unlike most other synapses in the brain, each individual cone synapse is connected to more than a dozen different types of post-synaptic neurons. In…
Liked by Xiaoting Ye
-
Our phase 1/2a clinical trial of EA-2353 for the treatment of #retinitispigmentosa has passed a key milestone, having completed the dose escalation…
Our phase 1/2a clinical trial of EA-2353 for the treatment of #retinitispigmentosa has passed a key milestone, having completed the dose escalation…
Liked by Xiaoting Ye
-
It's a big day at Nanoscope Therapeutics Inc. as we announce topline results from our Phase 2b RESTORE Trial of our optogenetic gene therapy for…
It's a big day at Nanoscope Therapeutics Inc. as we announce topline results from our Phase 2b RESTORE Trial of our optogenetic gene therapy for…
Liked by Xiaoting Ye
-
Last Friday was a rough one. Two things happened: I got laid off from Google and I went into labor to give birth to my second child. At a time when…
Last Friday was a rough one. Two things happened: I got laid off from Google and I went into labor to give birth to my second child. At a time when…
Liked by Xiaoting Ye
-
Friends, my team is impacted by Google's layoff. We have some of the best engineers who are open for new adventures: full-stack, thrilled to…
Friends, my team is impacted by Google's layoff. We have some of the best engineers who are open for new adventures: full-stack, thrilled to…
Liked by Xiaoting Ye
-
Today Nanoscope Therapeutics Inc. Therapeutics announces completion of full enrollment in our STARLIGHT Phase 2 Trial of MCO-010 gene therapy for…
Today Nanoscope Therapeutics Inc. Therapeutics announces completion of full enrollment in our STARLIGHT Phase 2 Trial of MCO-010 gene therapy for…
Liked by Xiaoting Ye
-
Today marks four years since I’ve joined Tinder. Tinder’s flame has provided warmth & comfort alongside exciting challenges & growth. I’ve had four…
Today marks four years since I’ve joined Tinder. Tinder’s flame has provided warmth & comfort alongside exciting challenges & growth. I’ve had four…
Liked by Xiaoting Ye
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Xiaoting Ye in United States
4 others named Xiaoting Ye in United States are on LinkedIn
See others named Xiaoting Ye